These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22997352)

  • 1. Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?
    Buja A; Boemo DG; Furlan P; Bertoncello C; Casale P; Baldovin T; Marcolongo A; Baldo V
    Eur J Prev Cardiol; 2014 Feb; 21(2):222-30. PubMed ID: 22997352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women.
    Smolina K; Ball L; Humphries KH; Khan N; Morgan SG
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):586-92. PubMed ID: 26462876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
    Redfors B; Angerås O; Råmunddal T; Petursson P; Haraldsson I; Dworeck C; Odenstedt J; Ioaness D; Ravn-Fischer A; Wellin P; Sjöland H; Tokgozoglu L; Tygesen H; Frick E; Roupe R; Albertsson P; Omerovic E
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No gender differences in prognosis and preventive treatment in patients with AMI without significant stenoses.
    Hansen KW; Hvelplund A; Abildstrøm SZ; Prescott E; Madsen M; Madsen JK; Jensen JS; Thuesen L; Thayssen P; Tilsted HH; Jørgensen E; Galatius S
    Eur J Prev Cardiol; 2012 Aug; 19(4):746-54. PubMed ID: 21724682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in acute myocardial infarction treatment between 1998 and 2007 in a Belgian area (Charleroi).
    Collart P; Coppieters Y; Levêque A
    Eur J Prev Cardiol; 2012 Aug; 19(4):738-45. PubMed ID: 21708835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.
    Tuppin P; Neumann A; Danchin N; Weill A; Ricordeau P; de Peretti C; Allemand H
    Arch Cardiovasc Dis; 2009 Apr; 102(4):279-92. PubMed ID: 19427605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.
    Urbinati S; Olivari Z; Gonzini L; Savonitto S; Farina R; Del Pinto M; Valbusa A; Fantini G; Mazzoni A; Maggioni AP;
    Eur J Prev Cardiol; 2015 Dec; 22(12):1548-56. PubMed ID: 25452625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use.
    Miller AL; Dib C; Li L; Chen AY; Amsterdam E; Funk M; Saucedo JF; Wang TY
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):662-71. PubMed ID: 22949495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary medical prevention after primary vascular surgery between 1996 and 2006: a shift towards more evidence-based treatment.
    Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
    Eur J Prev Cardiol; 2013 Oct; 20(5):763-70. PubMed ID: 22637739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
    Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
    Zeymer U; James S; Berkenboom G; Mohacsi A; Iñiguez A; Coufal Z; Sartral M; Paget MA; Norrbacka K; Ferrieres J; Bakhai A;
    Eur J Prev Cardiol; 2013 Apr; 20(2):218-28. PubMed ID: 22345684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term medication adherence in patients with ST-elevation myocardial infarction and primary percutaneous coronary intervention.
    Reuter H; Markhof A; Scholz S; Wegmann C; Seck C; Adler C; Michels G; Hoepp HW; Baldus S; Pfister R
    Eur J Prev Cardiol; 2015 Jul; 22(7):890-8. PubMed ID: 24938277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions.
    Ortolani P; Solinas E; Guastaroba P; Marino M; Casella G; Manari A; Piovaccari G; Ottani F; Varani E; Campo G; Marzocchi A; Merlini PA; Caminiti C; De Palma R; Ardissino D
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):421-9. PubMed ID: 22914306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.